Pharmacists at St. Jude Children’s Research Hospital in Memphis, Tenn., have started using 3D-printing technology to help produce compounded medications starting with hydrocortisone formulations.
The hospital is working to integrate the printers within existing U.S. Pharmacopoeia standards for nonsterile and hazardous drug compounding, according to a Sept. 11 news release from the American Society of Health-System Pharmacists.
Hospital pharmacists said the approach has the potential to improve medication precision and adherence for patients who need customized doses, especially in pediatrics and geriatrics.
